Theo dõi
Matti Nykter
Matti Nykter
Tampere University
Email được xác minh tại tuni.fi - Trang chủ
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
28392015
The evolutionary history of lethal metastatic prostate cancer
G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ...
Nature 520 (7547), 353-357, 2015
15122015
Critical assessment of automated flow cytometry data analysis techniques
N Aghaeepour, G Finak, FlowCAP Consortium, Dream Consortium, ...
Nature methods 10 (3), 228-238, 2013
6832013
Driver fusions and their implications in the development and treatment of human cancers
Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ...
Cell reports 23 (1), 227-238. e3, 2018
5692018
Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis
H Cheng, L Zhang, DE Cogdell, H Zheng, AJ Schetter, M Nykter, ...
PloS one 6 (3), e17745, 2011
5692011
Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer
M Annala, G Vandekerkhove, D Khalaf, S Taavitsainen, K Beja, ...
Cancer discovery 8 (4), 444-457, 2018
5172018
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ...
Cancer cell 23 (2), 186-199, 2013
4532013
Evaluation of methods for modeling transcription factor sequence specificity
MT Weirauch, A Cote, R Norel, M Annala, Y Zhao, TR Riley, ...
Nature biotechnology 31 (2), 126-134, 2013
4212013
Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer
AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ...
JNCI: Journal of the National Cancer Institute 109 (12), djx118, 2017
4202017
Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer
AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ...
JAMA oncology 2 (12), 1598-1606, 2016
3852016
Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals
V Litvak, SA Ramsey, AG Rust, DE Zak, KA Kennedy, AE Lampano, ...
Nature immunology 10 (4), 437-443, 2009
3352009
Gene expression dynamics in the macrophage exhibit criticality
M Nykter, ND Price, M Aldana, SA Ramsey, SA Kauffman, LE Hood, ...
Proceedings of the National Academy of Sciences 105 (6), 1897-1900, 2008
2722008
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ...
The Journal of clinical investigation 123 (2), 2013
2682013
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
Q Huang, T Whitington, P Gao, JF Lindberg, Y Yang, J Sun, MR Väisänen, ...
Nature genetics 46 (2), 126-135, 2014
2362014
Treatment outcomes and tumor loss of heterozygosity in germline DNA repair–deficient prostate cancer
M Annala, WJ Struss, EW Warner, K Beja, G Vandekerkhove, A Wong, ...
European urology 72 (1), 34-42, 2017
2352017
Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer
G Vandekerkhove, WJ Struss, M Annala, HML Kallio, D Khalaf, ...
European urology 75 (4), 667-675, 2019
1932019
Immunogenomic landscape of hematological malignancies
O Dufva, P Pölönen, O Brück, MAI Keränen, J Klievink, J Mehtonen, ...
Cancer Cell 38 (3), 380-399. e13, 2020
1822020
Circulating tumor DNA reveals clinically actionable somatic genome of metastatic bladder cancer
G Vandekerkhove, T Todenhöfer, M Annala, WJ Struss, A Wong, K Beja, ...
Clinical Cancer Research 23 (21), 6487-6497, 2017
1702017
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer
KA Leinonen, OR Saramäki, B Furusato, T Kimura, H Takahashi, S Egawa, ...
Cancer epidemiology, biomarkers & prevention 22 (12), 2333-2344, 2013
1642013
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
L Latonen, E Afyounian, A Jylhä, J Nättinen, U Aapola, M Annala, ...
Nature communications 9 (1), 1176, 2018
1592018
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20